These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21199607)

  • 1. Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas.
    Huang TL; Li CF; Huang HY; Fang FM
    Chang Gung Med J; 2010; 33(6):619-27. PubMed ID: 21199607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes.
    Fang FM; Li CF; Chien CY; Rau KM; Huang HY
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
    Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
    Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
    Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma.
    Fang FM; Tsai WL; Chien CY; Chen HC; Hsu HC; Huang TL; Lee TF; Huang HY; Lee CH
    J Clin Oncol; 2010 Oct; 28(28):4384-9. PubMed ID: 20713853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
    Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.
    Richardson CM; Richardson D; Swinson DE; Swain WA; Cox G; O'Byrne KJ
    Lung Cancer; 2005 Apr; 48(1):47-57. PubMed ID: 15777970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
    Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
    Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
    Edwards JG; Swinson DE; Jones JL; Waller DA; O'Byrne KJ
    Lung Cancer; 2006 Dec; 54(3):399-407. PubMed ID: 17049671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories.
    Ma J; Liu L; Tang L; Zong J; Lin A; Lu T; Cui N; Cui C; Li L
    Clin Cancer Res; 2007 Mar; 13(5):1445-52. PubMed ID: 17332287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
    Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
    Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of epidermal growth factor receptor activation to metastasis-free survival of nasopharyngeal carcinoma patients].
    Yuan TZ; Li XX; Cao Y; Qian CN; Zeng MS; Guo X
    Ai Zheng; 2008 May; 27(5):449-54. PubMed ID: 18479591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.